IHC of IgG4 on an FFPE Tonsil Tissue

Specification Sheets
Safety Data Sheet

SDS

Intended Use For In Vitro Diagnostic Use
Summary and Explanation IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. As these patients tend to respond favorably to steroid treatment, it is important to recognize this entity and differentiate it from such mimics as lymphoma.
Clinical manifestations are apparent in the pancreas, bile duct, gallbladder, lacrimal gland, salivary gland, retroperitoneum, kidney, lung, breast, thyroid, and prostate. Immunohistochemical analyses in the case of IgG4-related sclerosing disease not only exhibits significantly more IgG4- positive plasma cells in affected tissues but also significantly higher IgG4/ IgG ratios (typically 30%).
Antibody Type Mouse Monoclonal Clone BSB-96
Isotype IgG1 Reactivity Paraffin, Frozen
Localization Cytoplasmic Control Colon, Tonsil, Spleen
Presentation IgG4 is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Availability
Catalog No. Antibody Type Dilution Volume/QTY
BSB 6807 Prediluted Ready-To-Use 3.0 ml
BSB 6808 Prediluted Ready-To-Use 7.0 ml
BSB 6809 Prediluted Ready-To-Use 15.0 ml
BSB 6810 Concentrated 1:50-1:200 0.1 ml
BSB 6811 Concentrated 1:50-1:200 0.5 ml
BSB 6812 Concentrated 1:50-1:200 1.0 ml
BSB 6813 Control Slides 5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.
Related Products